Skip to main content

Regulatory and Washington

  • NCPA and three Oregon legislators push for greater oversight, transparency of PBMs

    ALEXANDRIA, Va. — The National Community Pharmacists Association on Wednesday urged Oregon state lawmakers to pass a series of bills that would "collectively reduce red tape for pharmacists caring for patients, give consumers greater pharmacy choice at no extra cost, and keep more revenue within the state."

    NCPA has identified four issues of import:

  • NCPDP releases updated acetaminophen white paper

    SCOTTSDALE, Ariz. — A standards-development organization for the pharmacy services industry has updated a white paper on protecting consumers and patients from accidental overdoses of the painkiller acetaminophen.

    The NCPDP announced the updated white paper, "NCPDP Recommendations for Improved Prescription Container Labels for Medicines Containing Acetaminophen Version 1.1."

  • FDA approves Genzyme drug for rare cholesterol disorder

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating a rare cholesterol disorder, the agency said.

    The FDA announced the approval of Kynamro (mipomersen sodium), made by Genzyme for the treatment of homozygous familial hypercholesterolemia, or HoFH. Kynamro has been approved as an orphan drug, a designation the FDA gives to drugs that treat diseases affecting fewer than 200,000 people.

  • Second Medication Adherence Team Challenge launched

    WASHINGTON — A group of organizations has launched a nationwide competitive outreach project to enlist students studying to become healthcare professionals to find new ways to raise awareness about medication adherence as a public health issue.

  • Penniless: Most Canadian retailers ready for phase-out of 1-cent coins, retailing group says

    TORONTO — Most retailers in Canada are ready for a phase-out of 1-cent coins, a national retailing trade group said Wednesday.

    The Retail Council of Canada said the majority of the country's retail businesses were prepared for the disappearance of the penny and will follow the government's proposals for determining prices.

  • FDA panel recommends approval for Boehringer Ingelheim COPD drug

    RIDGEFIELD, Conn. — A panel of Food and Drug Administration experts has recommended approval for an experimental drug made by Boehringer Ingelheim for chronic obstructive pulmonary disease, the drug maker said.

  • Citizen's Petition asks that behind-the-counter status be mandated for St. John's Wort

    SAN RAFAEL, Calif. — Pharmacists Planning Services, Inc. earlier this month filed a Citizen's Petition with the Food and Drug Administration calling to move St. John's Wort, a mood enhancing supplement, behind the counter. 

  • New York Times: Battle against biogenerics is on

    NEW YORK — The battle against biogenerics is on, noted a report published in The New York Times Tuesday.  As many as eight states have introduced legislation that would restrict generic competition of biological pharamceuticals so far this year and one, the Virginia House of Delegates, already passed such a measure by a 91-to-6 vote. 

X
This ad will auto-close in 10 seconds